EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $43,839,000 | +158.7% | 333,176 | -0.6% | 0.22% | +109.6% |
| Q3 2020 | $16,945,000 | +3.3% | 335,349 | -2.5% | 0.10% | -18.8% |
| Q2 2020 | $16,398,000 | -6.5% | 343,989 | -3.9% | 0.13% | -39.0% |
| Q1 2020 | $17,540,000 | -17.1% | 358,034 | -2.9% | 0.21% | -4.5% |
| Q4 2019 | $21,158,000 | – | 368,664 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |